HomeStock ScreenerChemfab AlkalisFinancial Statements

Chemfab Alkalis Complete Financial Statements

8 Years of Data
2026 - 2019

In FY2026, Chemfab Alkalis (CHEMFAB) reported revenue ₹78 Cr, net profit ₹1 Cr and EPS ₹0.34, with a net profit margin of 1.3% and ROE of 0.3%. Full financial statements from FY2019 to FY2026 (8 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Chemfab Alkalis stock price NSE.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 1.28% 2026 data
EBITDA Margin 14.10% 2026 data
Operating Margin 11.00% 2026 data
Return on Assets 0.17% 2026 data
Return on Equity 0.27% 2026 data

Balance Sheet Ratios

Current Ratio 1.44 2026 data
Equity Ratio 64.99% 2026 data
Asset Turnover 0.14 2026 data

CHEMFAB Revenue, Net Profit & EBITDA — Year-on-Year Growth

CHEMFAB YoY (Mar 2025 vs Mar 2026) — revenue -17.0%, net profit +111.1%, EBITDA +120.0%, expenses -25.8%. Review CHEMFAB P/E comparison to evaluate earnings-based valuation against sector peers.

Revenue Growth
-17.0%
Year-over-Year
Net Profit Growth
+111.1%
Year-over-Year
EBITDA Growth
+120.0%
Year-over-Year
Expense Growth
-25.8%
Year-over-Year
Assets Growth
+10.5%
Year-over-Year
Equity Growth
-1.3%
Year-over-Year
Operating Cash Flow Growth
+29.0%
Year-over-Year
Investing Cash Flow Growth
+21.8%
Year-over-Year
Financing Cash Flow Growth
+268.8%
Year-over-Year

CHEMFAB Income Statement — Revenue, EBITDA & Net Profit

Chemfab Alkalis revenue ₹78 Cr, EBITDA ₹11 Cr, net profit ₹1 Cr, EPS ₹0.34 (2026) — net profit margin 1.3%. Explore CHEMFAB value investing to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021 Sept 2020 Mar 2020 Jun 2020 Dec 2020 Dec 2019
Revenue 78 78 94 93 71 83 84 79 86 81 75 83 88 77 91 99 86 59 52 49 78 43 43 41 47 51
Expenses 66 71 89 80 66 72 70 68 72 69 49 64 71 54 69 63 59 52 48 39 55 37 41 33 40 36
EBITDA 11 7 5 13 5 11 14 11 15 12 26 19 17 24 22 36 27 7 4 10 23 6 2 8 6 15
Operating Profit Margin % 11.00% 7.00% 4.00% 12.00% 3.00% 12.00% 15.00% 11.00% 14.00% 14.00% 33.00% 20.00% 18.00% 30.00% 22.00% 36.00% 29.00% 11.00% 6.00% 18.00% 29.00% 14.00% 1.00% 20.00% 13.00% 29.00%
Depreciation 8 7 11 6 8 9 6 7 10 6 6 5 5 6 6 6 6 5 5 5 6 5 7 5 5 7
Interest 2 2 2 2 2 1 0 1 1 0 0 0 0 0 0 0 0 0 1 1 0 1 1 1 1 1
Profit Before Tax 1 -1 -7 5 -5 1 8 3 4 7 21 14 11 18 17 30 21 1 -2 4 17 1 -6 2 1 8
Tax 1 1 2 2 0 1 3 2 2 2 5 4 4 5 4 9 6 0 10 1 5 0 -8 1 -1 2
Net Profit 1 -2 -9 3 -4 -1 5 1 2 4 15 10 7 13 13 21 15 1 -12 3 12 1 2 2 1 6
Earnings Per Share (₹) 0.34 -1.40 -6.41 1.77 -3.09 -0.37 3.80 0.63 1.32 3.03 10.77 6.70 5.00 9.22 9.08 15.10 10.56 0.58 -8.31 2.18 8.56 0.46 1.27 1.20 0.88 3.99

CHEMFAB Balance Sheet — Assets, Liabilities & Shareholders' Equity

CHEMFAB total assets ₹577 Cr, total equity ₹375 Cr, total liabilities ₹ Cr (2026) — ROE 0.3%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020
ASSETS
Total Assets 577 522 500 412 352 335 348
Current Assets 127 119 101 124 92 76 51
Fixed Assets 418 317 247 192 194 202 195
Capital Work in Progress 31 36 74 32 8 3 35
Investments 26 16 6 68 31 24 1
Other Assets 0 152 174 121 119 105 118
LIABILITIES
Total Liabilities
Current Liabilities 88 70 21 5 4 26 24
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 375 380 387 361 298 267 276
Share Capital 14 14 14 14 14 14 14
Reserves & Surplus 361 366 373 347 284 253 262

CHEMFAB Cash Flow Statement — Operating, Investing & Financing

Chemfab Alkalis operating cash flow ₹40 Cr, investing ₹-86 Cr, financing ₹59 Cr, net cash flow ₹13 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Operating Activities 40 31 93 55 45 54
Investing Activities -86 -110 -48 -21 -6 -58
Financing Activities 59 16 -9 -25 -16 3
Net Cash Flow 13 -62 36 9 23 -1